Quest Diagnostics 관리
관리 기준 확인 4/4
현재 CEO에 대한 정보가 충분하지 않습니다.
주요 정보
Jim Davis
최고 경영자
US$12.7m
총 보상
| CEO 급여 비율 | 9.3% |
| CEO 임기 | 2yrs |
| CEO 소유권 | 0.07% |
| 경영진 평균 재임 기간 | 4yrs |
| 이사회 평균 재임 기간 | 5.2yrs |
최근 관리 업데이트
Recent updates
Investors Met With Slowing Returns on Capital At Quest Diagnostics (NYSE:DGX)
Nov 12
Earnings Update: Quest Diagnostics Incorporated (NYSE:DGX) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts
Oct 25Quest Diagnostics: Organic Growth Leads To Q3 Earnings Beat
Oct 24Why Investors Shouldn't Be Surprised By Quest Diagnostics Incorporated's (NYSE:DGX) P/E
Oct 23Quest Diagnostics: The Better Half Of An Emerging Healthcare Duopoly
Oct 15These 4 Measures Indicate That Quest Diagnostics (NYSE:DGX) Is Using Debt Reasonably Well
Aug 30Should You Think About Buying Quest Diagnostics Incorporated (NYSE:DGX) Now?
Aug 12Quest Diagnostics: Beat Down After Beating Q2 Estimates
Jul 28The Price Is Right For Quest Diagnostics Incorporated (NYSE:DGX)
Jul 12Quest Diagnostics: On A Quest For Growth
Jul 12Quest Diagnostics (NYSE:DGX) Hasn't Managed To Accelerate Its Returns
May 14Quest Diagnostics: Let's Keep Waiting
May 08Results: Quest Diagnostics Incorporated Beat Earnings Expectations And Analysts Now Have New Forecasts
Apr 26We Think Quest Diagnostics (NYSE:DGX) Can Stay On Top Of Its Debt
Apr 23Unpleasant Surprises Could Be In Store For Quest Diagnostics Incorporated's (NYSE:DGX) Shares
Apr 02Quest Diagnostics (NYSE:DGX) Is Paying Out A Larger Dividend Than Last Year
Mar 15Quest Diagnostics (NYSE:DGX) Has Announced That It Will Be Increasing Its Dividend To $0.75
Feb 06Quest Diagnostics: Post-COVID Normalization Pretty Much Done
Feb 05Quest Diagnostics (NYSE:DGX) Seems To Use Debt Quite Sensibly
Jan 11Why We're Not Concerned About Quest Diagnostics Incorporated's (NYSE:DGX) Share Price
Dec 24Quest Diagnostics: Market Overreaction Creates Investment Opportunity
Dec 08Is There Now An Opportunity In Quest Diagnostics Incorporated (NYSE:DGX)?
Dec 06Quest Diagnostics' (NYSE:DGX) Returns Have Hit A Wall
Nov 18Quest Diagnostics: Moving Past Covid
Oct 25Here's Why Quest Diagnostics (NYSE:DGX) Can Manage Its Debt Responsibly
Sep 25What Does Quest Diagnostics Incorporated's (NYSE:DGX) Share Price Indicate?
Sep 04Quest Diagnostics: Q2 Earnings Reveal Promising Growth Trends Despite Dwindling COVID Testing Revenues
Aug 15Quest Diagnostics (NYSE:DGX) Has More To Do To Multiply In Value Going Forward
Aug 13Quest Diagnostics Incorporated (NYSE:DGX) Shares Could Be 46% Below Their Intrinsic Value Estimate
Jul 11Is Quest Diagnostics (NYSE:DGX) A Risky Investment?
Jun 09Quest Diagnostics: Healthier Diagnosis
May 30Is It Time To Consider Buying Quest Diagnostics Incorporated (NYSE:DGX)?
May 24Quest Diagnostics (NYSE:DGX) Has More To Do To Multiply In Value Going Forward
May 09An Intrinsic Calculation For Quest Diagnostics Incorporated (NYSE:DGX) Suggests It's 24% Undervalued
Mar 22What Does Quest Diagnostics Incorporated's (NYSE:DGX) Share Price Indicate?
Feb 19CEO 보상 분석
| 날짜 | 총 보상 | 급여 | 회사 수익 |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | US$838m |
| Jun 30 2024 | n/a | n/a | US$836m |
| Mar 31 2024 | n/a | n/a | US$842m |
| Dec 31 2023 | US$13m | US$1m | US$850m |
| Sep 30 2023 | n/a | n/a | US$759m |
| Jun 30 2023 | n/a | n/a | US$790m |
| Mar 31 2023 | n/a | n/a | US$789m |
| Dec 31 2022 | US$12m | US$806k | US$942m |
| Sep 30 2022 | n/a | n/a | US$1b |
| Jun 30 2022 | n/a | n/a | US$1b |
| Mar 31 2022 | n/a | n/a | US$2b |
| Dec 31 2021 | US$4m | US$625k | US$2b |
| Sep 30 2021 | n/a | n/a | US$2b |
| Jun 30 2021 | n/a | n/a | US$2b |
| Mar 31 2021 | n/a | n/a | US$2b |
| Dec 31 2020 | US$4m | US$577k | US$1b |
| Sep 30 2020 | n/a | n/a | US$1b |
| Jun 30 2020 | n/a | n/a | US$749m |
| Mar 31 2020 | n/a | n/a | US$771m |
| Dec 31 2019 | US$3m | US$590k | US$835m |
| Sep 30 2019 | n/a | n/a | US$709m |
| Jun 30 2019 | n/a | n/a | US$707m |
| Mar 31 2019 | n/a | n/a | US$720m |
| Dec 31 2018 | US$3m | US$590k | US$733m |
| Sep 30 2018 | n/a | n/a | US$860m |
| Jun 30 2018 | n/a | n/a | US$808m |
| Mar 31 2018 | n/a | n/a | US$782m |
| Dec 31 2017 | US$3m | US$590k | US$769m |
보상 대 시장: Jim 의 총 보상 ($USD 12.67M )은 US 시장에서 비슷한 규모의 회사의 평균 수준입니다( $USD 12.73M ).
보상과 수익: Jim 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.
CEO
Jim Davis (61 yo)
2yrs
테뉴어
US$12,673,834
보상
Mr. James E. Davis, also known as Jim, serves as Chief Executive Officer and President at Quest Diagnostics Incorporated since November 1, 2022 and serves as its Director since November 2022. He served as...
리더십 팀
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| Chairman | 2yrs | US$12.67m | 0.067% $ 12.1m | |
| Executive VP & CFO | 2.3yrs | US$3.98m | 0.016% $ 2.8m | |
| Senior VP & General Counsel | 25.3yrs | US$2.25m | 0.039% $ 7.1m | |
| Executive Vice President of Regional Businesses | no data | US$3.16m | 0.058% $ 10.5m | |
| Senior Vice President of Clinical Solutions | 2.3yrs | US$2.02m | 0.010% $ 1.9m | |
| Senior VP | 5.6yrs | 데이터 없음 | 0.032% $ 5.7m | |
| Senior VP | less than a year | 데이터 없음 | 데이터 없음 | |
| Vice President of Investor Relations | no data | 데이터 없음 | 데이터 없음 | |
| Senior VP & Chief Compliance Officer | 2.1yrs | 데이터 없음 | 데이터 없음 | |
| Senior VP & Chief Communications Officer | 28yrs | 데이터 없음 | 데이터 없음 | |
| Senior VP & Chief Human Resources Officer | 6.8yrs | 데이터 없음 | 데이터 없음 | |
| Senior Vice President of Strategy | 8.8yrs | 데이터 없음 | 데이터 없음 |
4.0yrs
평균 재임 기간
61yo
평균 연령
경험이 풍부한 관리: DGX 의 관리팀은 경험 ( 4 년 평균 재직 기간)으로 간주됩니다.
이사회 구성원
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| Chairman | 2yrs | US$12.67m | 0.067% $ 12.1m | |
| Independent Director | 10.8yrs | US$315.44k | 0.022% $ 4.0m | |
| Director | less than a year | 데이터 없음 | 데이터 없음 | |
| Lead Independent Director | 12.9yrs | US$345.94k | 데이터 없음 | |
| Independent Director | 19.9yrs | US$342.12k | 데이터 없음 | |
| Independent Director | 5.8yrs | US$312.33k | 0.0026% $ 462.7k | |
| Independent Director | 10.3yrs | US$315.73k | 0.016% $ 2.9m | |
| Independent Director | 4.7yrs | US$300.44k | 데이터 없음 | |
| Independent Director | 3.3yrs | US$300.44k | 데이터 없음 | |
| Independent Director | 1.5yrs | US$280.41k | 데이터 없음 |
5.2yrs
평균 재임 기간
65yo
평균 연령
경험이 풍부한 이사회: DGX 의 이사회는 경험(평균 재직 기간 5.2 년)으로 간주됩니다.